Clinical Overview

Wolverine combines two research peptides—BPC-157 (a synthetic pentadecapeptide derived from gastric protein) and TB-500 (a synthetic fragment modeled on thymosin beta-4’s actin-binding domain). The stack is used in advanced experimental designs that explore cytoskeletal dynamics, angiogenic signaling, and extracellular-matrix (ECM) remodeling. Investigations commonly focus on tissue homeostasis, stress-response pathways, and cellular migration frameworks.

Mechanism of Action

BPC-157: Reported to interact with growth-factor and nitric-oxide–linked pathways to support cytoprotection and endothelial function; research models evaluate effects on VEGF signaling, fibroblast activity, and ECM turnover.
TB-500 (Tβ4-fragment): Modeled on an actin-sequestering motif implicated in cell migration and cytoskeletal remodeling; preclinical systems assess impacts on lamellipodia formation, integrin dynamics, and re-epithelialization kinetics.
Stack Rationale: Parallel interrogation of endothelial/angiogenic signaling (BPC-157) and actin-driven cell migration programs (TB-500) to study coordinated phases of tissue remodeling in vitro and in vivo research settings.

Research Applications

Endothelial biology and angiogenesis assays • Fibroblast/keratinocyte migration models • ECM synthesis and remodeling studies • Cytoskeletal signaling (actin dynamics, focal adhesion turnover) • Stress-response and cytoprotection paradigms in translational research.

Purity & Quality Assurance

Revitalized Health peptides are produced under cGMP-aligned conditions with pharmaceutical-grade inputs. Each component (BPC-157 and TB-500) is confirmed at ≥99% purity via HPLC with identity verified by LC-MS/MS. Lots undergo appearance/solubility checks and microbial/endotoxin screening to research-grade specifications. Batch-specific Certificates of Analysis are available to document analytical methods and results.

Storage & Stability

Store lyophilized vials at 2–8 °C, protected from light and moisture. After reconstitution with bacteriostatic water, maintain at 2–8 °C and utilize within 20 days. Avoid repeated freeze–thaw cycles to preserve peptide integrity and receptor/target interaction fidelity.

Research Disclaimer

For laboratory research use only. Not intended for human consumption, therapeutic, or diagnostic application. Supplied exclusively to qualified professionals conducting controlled scientific investigations.

Formulated for research applications. Purity, identity, and lot analytics available per batch. Not medical advice.

Mechanism Strength
86/100
Angiogenesis • cell migration • ECM repair
Tissue Repair Impact
88/100
Tendon/ligament • microvasculature (models)
Evidence Level
66/100
Strong preclinical; limited human data
Safety & Tolerability
90/100
Common: mild ISR/GI; avoid treatment claims
PK / PD
Angiogenesis (VEGF/FGF cues)
Cell Migration / Actin Dynamics (TB-500)
FAK–Paxillin / ECM Organization (BPC-157)
Inflammatory Modulation (TNF/NO balance)
Mechanism & Testing

Identity: Wolverine is a two-peptide stack combining BPC-157 (pentadecapeptide) with TB-500 (a thymosin β4–derived fragment associated with actin-mediated cell motility).
Mode: BPC-157: cytoprotective pro-repair signaling; supports endothelial migration and microvascular stability; influences FAK–paxillin/NO pathways and ECM collagen alignment in models. TB-500: linked to actin cytoskeleton modulation and cell migration, facilitating re-epithelialization and angiogenic sprouting; complementary to BPC-157’s ECM/vascular cues. Stack rationale: pair angiogenic/migratory cues with ECM organization to support tendon/ligament, soft-tissue, and microvascular repair phenotypes in preclinical systems.
Analytics: HPLC/LC-MS identity & purity for each peptide; peptide content and counter-ion profiling; sterility/endotoxin where applicable; stability (accelerated/real-time). PD (exploratory): ultrasound or MRI for tissue integrity, wound/tendon scoring, capillary density (IHC/CD31), cytokine & MMP/TIMP panels; functional measures (ROM/strength) in observational settings. Monitoring: ISR, GI tolerance (if oral), hypersensitivity history; avoid implying disease treatment.

Educational, research-style description of a two-peptide repair stack. Not medical advice or a treatment claim.